230 related articles for article (PubMed ID: 2603642)
1. Toxic shock syndrome toxin-1 (TSST-1) production in staphylococcal infections and serological implications with patients and healthy controls.
Naidu AS; Vörös S; Löczi G; Kienle Z; Brasch B; Emödy L
Acta Microbiol Hung; 1989; 36(1):19-24. PubMed ID: 2603642
[TBL] [Abstract][Full Text] [Related]
2. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
[TBL] [Abstract][Full Text] [Related]
3. Production of toxic shock syndrome toxin-1 (TSST-1) associated with Staphylococcus aureus from a pyogenic skin infection.
Naidu AS; Rathna K; Naidu S; Rao PN; Rajyalakshmi K
Acta Microbiol Hung; 1988; 35(1):35-40. PubMed ID: 3394489
[TBL] [Abstract][Full Text] [Related]
4. Risk involvement with Staphylococcus aureus exotoxins among pyogenic skin infections with special reference to toxic shock syndrome.
Naidu S; Rajyalakshmi K; Naidu AS
Acta Microbiol Hung; 1989; 36(1):7-12. PubMed ID: 2603647
[TBL] [Abstract][Full Text] [Related]
5. Virulence factors of Staphylococcus aureus strains causing infective endocarditis--a comparison with strains from skin infections.
Hogevik H; Söderquist B; Tung HS; Olaison L; Westberg A; Rydén C; Tarkowski A; Andersson R
APMIS; 1998 Sep; 106(9):901-8. PubMed ID: 9808417
[TBL] [Abstract][Full Text] [Related]
6. Toxic shock syndrome--the role of the toxin.
Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
[TBL] [Abstract][Full Text] [Related]
7. Genotypic characterization of toxic shock syndrome toxin-1-producing strains of Staphylococcus aureus isolated in the Czech Republic.
Hrstka R; Růzicková V; Petrás P; Pantůcek R; Rosypal S; Doskar J
Int J Med Microbiol; 2006 Feb; 296(1):49-54. PubMed ID: 16423687
[TBL] [Abstract][Full Text] [Related]
8. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
9. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
Adesiyun AA; Lenz W; Schaal KP
Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the anti TSST-1 serostatus of hospital personnel in Nigeria.
Olusanya O; Naidu AS
East Afr Med J; 1991 Jul; 68(7):507-14. PubMed ID: 1756702
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
Vischer WA; Stalder H; Faupel DM
Schweiz Med Wochenschr; 1985 Aug; 115(35):1196-9. PubMed ID: 4048915
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.
Christensson B; Johansson PJ; Oxelius VA
Clin Exp Immunol; 1986 Nov; 66(2):443-9. PubMed ID: 3815898
[TBL] [Abstract][Full Text] [Related]
13. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
Dickgiesser N; Brombacher A; Wiest W
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
[TBL] [Abstract][Full Text] [Related]
15. Purpura fulminans due to Staphylococcus aureus.
Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
[TBL] [Abstract][Full Text] [Related]
16. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
17. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
19. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment.
Andrews MM; Parent EM; Barry M; Parsonnet J
Clin Infect Dis; 2001 May; 32(10):1470-9. PubMed ID: 11317249
[TBL] [Abstract][Full Text] [Related]
20. [A patient with toxic shock syndrome following correction of the nasal septum].
Schweitzer DH; Moffie BG; van der Mey AG; Thompson J
Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2146-8. PubMed ID: 2247173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
